Recent Developments Boosted TScan (TCRX) Stock Up
TScan Therapeutics, Inc. (NASDAQ: TCRX) experienced a notable ascent of 10.46% on Tuesday, culminating in a closing value of $6.76. This surge in TScan’s stock value was precipitated by the disclosure of a significant corporate development. TScan (TCRX) has officially communicated its intention to convene a virtual Key Opinion Leader (KOL) event scheduled for Monday, […]